53
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Evaluating targets and costs of treatment for secondary hyperparathyroidism in incident dialysis patients: the FARO-2 study

, , , , , , , , & show all
Pages 1-6 | Published online: 16 Dec 2014

References

  • Centers for Disease Control and PreventionPrevalence of chronic kidney disease and associated risk factors – United States Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5608a2.htmAccessed July 24, 2014
  • Italian Registry of Dialysis and Transplantation. Report 2010 Available from: http://www.sin-ridt.org/web/eventi/RIDT/registro_italiano.cfmAccessed July 24, 2014
  • JansenDLHeijmansMJRijkenMIllness perceptions and treatment perceptions of patients with chronic kidney disease: different phases, different perceptions?Br J Health Psychol201318224426223126527
  • WyldMMortonRLHayenAHowardKWebsterACA systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatmentsPLoS Med201299e100130722984353
  • MujaisSKStoryKBrouilletteJHealth-related quality of life in CKD patients: correlates and evolution over timeClin J Am Soc Nephrol2009481293130119643926
  • Abdel-KaderKMyaskoversuskyLKarpovIIndividual quality of life in chronic kidney disease: influence of age and dialysis modalityClin J Am Soc Nephrol20094471171819339411
  • ProcacciniDAAngeliniPAucellaFApulia Nephrology Quality of Life StudyHealth-related quality of life in patients with chronic kidney diseaseG Ital Nefrol2008256694671 Italian19048570
  • Chronic Kidney Disease Initiative. Protecting kidney health Available from: http://www.cdc.gov/diabetes/projects/pdfs/CKD_Factsheet.pdfAccessed July 24, 2014
  • LeveyASAtkinsRCoreshJChronic kidney disease as a global public health problem: approaches and initiatives – a position statement from Kidney Disease Improving Global OutcomesKidney Int200772324725917568785
  • JoyMSKaragiannisPCPeyerlFWOutcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatmentJ Manag Care Pharm200713539741117605511
  • Fondazione CENSISSubstitution treatment of renal function in Italy: clinical, economic and social aspects Available from: http://www.censis.it/14?shadow_ricerca=5688Accessed July 24, 2014 Italian
  • CicchettiARuggeriMCodellaPRidolfiAThe social and health costs of chronic renal failureFarmeconomia e Percorsi Terapeutici20111212128 Italian
  • JeantetAPiccoliGBPacittiACosts of dialysis in hospitalised patients with acute or chronic renal failure, according to area of treatmentG Ital Nefrol2002193308315 Italian12195399
  • PontorieroGPozzoniPVecchioLDLocatelliFInternational study of health care organization and financing of renal replacement therapy in Italy: an evolving realityInt J Health Care Finance Econ200772–320121517641969
  • TomaselloSSecondary hyperparathyroidism and chronic kidney diseaseDiabetes Spectr20082111925
  • BlockGAKlassenPSLazarusJMOfsthunNLowrieEGChertowGMMineral metabolism, mortality, and morbidity in maintenance hemodialysisJ Am Soc Nephrol20041582208221815284307
  • FloegeJKimJIrelandESerum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis populationNephrol Dial Transplant20112661948195520466670
  • CoenGManniMMantellaDAre PTH serum levels predictive of coronary calcifications in haemodialysis patients?Nephrol Dial Transplant200722113262326717597083
  • MazzaferroSCozzolinoMMarangellaMStrippoliGFMessaPCalcimimetics, phosphate binders, vitamin D and its analogues for treating secondary hyperparathyroidism in chronic kidney disease: guideline from the Italian Society of NephrologyG Ital Nefrol200724Suppl 37107124 Italian17458822
  • ChiroliSMattinCBelozeroffVPerraultLMitchellDGioniIImpact of mineral and bone disorder on healthcare resource use and associated costs in the European Fresenius medical care dialysis population: a retrospective cohort studyBMC Nephrol20121314023106934
  • SchumockGTAndressDLMarxSESterzRJoyceATKalantar-ZadehKAssociation of secondary hyperparathyroidism with CKD progression, health care costs and survival in diabetic predialysis CKD patientsNephron Clin Pract20091131c54c6119590235
  • RoggeriDPMazzaferroSBrancaccioDPharmacological control of secondary hyperparathyroidism in hemodialysis subjects: a cost consequences analysis of data from the FARO studyJ Med Econ201215618